HYOU1, regulated by LPLUNC1, is up-regulated in nasopharyngeal carcinoma and associated with poor prognosis

Journal of Cancer

Volumn 7, Issue 4, 2016, Pages 367-376

  Zhou, Yujuan ^a   Liao, Qianjin ^a   Li, Xiayu ^a   Wang, Hui ^a   Wei, Fang ^a   Chen, Jie ^a   Yang, Jing ^a   Zeng, Zhaoyang ^a   Guo, Xiaofang ^a   Chen, Pan ^a   Zhang, Wenling ^a   Tang, Ke ^a   Li, Xiaoling ^a   Xiong, Wei ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

2 D DIGE; HYOU1; LPLUNC1; MALDI TOF TOF MS MS; Nasopharyngeal carcinoma; Proteomics

Indexed keywords

CHAPERONE; LUNG AND NASAL EPITHELIUM CLONE 1 PROTEIN; MESSENGER RNA; OXYGEN REGULATED PROTEIN 150; PROTEIN; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEOMICS; RNA ISOLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84971571591     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.13695     Document Type: Article

References (35)

1. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005; 365: 2041-54.
2. Ng WT, Yuen KT, Au KH, et al. Staging of nasopharyngeal carcinoma-the past, the present and the future. Oral Oncol. 2014; 50: 549-54.
3. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1765-77.
4. Gu AD, Zeng MS, Qian CN. The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiation. Int J Mol Sci. 2012; 13: 13737-47.
5. Shen Y, Zhang S, Sun R, et al. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients. Emerg Microbes Infect. 2015; 4: e20.
6. Armstrong RW, Imrey PB, Lye MS, et al. Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol. 2000; 29: 991-8.
7. Xiong W, Zeng ZY, Xia JH, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004; 64: 1972-4.
8. Zeng Z, Zhou Y, Zhang W, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006; 8: 156-60.
9. Liao Q, Guo X, Li X, et al. Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol. 2012; 138: 57-64.
10. Bingle CD, Seal RL, Craven CJ. Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. Biochem Soc Trans. 2011; 39: 977-83.
11. Bingle CD, Gorr SU. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int J Biochem Cell Biol. 2004; 36:2144-52.
12. Bingle CD, Wilson K, Lunn H, et al. Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts. Histochem Cell Biol. 2010; 133: 505-15.
13. Zhang B, Nie X, Xiao B, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer. 2003; 38: 80-90.
14. Liao Q, Zeng Z, Guo X, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene. 2014; 33: 2098-109.
15. Yang Y, Liao Q, Wei F, et al. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One. 2013; 8: e62869.
16. Stojadinovic A, Hooke JA, Shriver CD, et al. HYOU1/Orp150 expression in breast cancer. Med Sci Monit. 2007; 13: BR231-239.
17. Slaby O, Sobkova K, Svoboda M, et al. Significant overexpression of Hsp110 gene during colorectal cancer progression. Oncol Rep. 2009; 21: 1235-41.
18. Kusaczuk M, Cechowska-Pasko M. Molecular chaperone ORP150 in ER stress-related diseases. Curr Pharm Des. 2013; 19: 2807-18.
19. Liao Q, Guo X, Li X, et al. Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis. Eur J Cancer Prev. 2013; 22: 68-76.
20. Meng QW, Sun LC, Li M, et al. Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer. J. Cancer. 2015; 6: 990-995.
21. Shen SH, Gu LJ, Liu PQ, et al. Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells. Chin Med J (Engl). 2008; 121: 463-8.
22. Chen ZT, Liang ZG, Zhu XD. A Review: Proteomics in Nasopharyngeal Carcinoma. Int J Mol Sci. 2015; 16: 15497-530.
23. Zeng GQ, Cheng AL, Tang J, et al. Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses. 2013; 81: 68-70.
24. Cheng AL, Huang WG, Chen ZC, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res. 2008; 14: 435-45.
25. Huang WG, Cheng AL, Chen ZC, et al. Targeted proteomic analysis of 14-3-3sigma in nasopharyngeal carcinoma. Int J Biochem Cell Biol. 2010; 42: 137-47.
26. Feng XP, Yi H, Li MY, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 2010; 70: 3450-62.
27. Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol Cancer Ther. 2006; 5: 253-60.
28. Liu A, Huang W, Zeng G, et al. Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma. Mol Med Rep. 2014; 10: 3059-67.
29. Biaoxue R, Xiguang C, Shuanying Y. Annexin A1 in malignant tumors: current opinions and controversies. Int J Biol Markers. 2014; 29: e8-20.
30. Theiss AL, Sitaraman SV. The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta. 2011; 1813: 1137-43.
31. Gao YY, Liu BQ, Du ZX, et al. Implication of oxygen-regulated protein 150 (ORP150) in apoptosis induced by proteasome inhibitors in human thyroid cancer cells. J Clin Endocrinol Metab. 2010; 95: E319-26.
32. Miyagi T, Hori O, Koshida K, et al. Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells. Int J Urol. 2002; 9: 577-85.
33. Asahi H, Koshida K, Hori O, et al. Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU Int. 2002; 90: 462-6.
34. Tian Y, Almaraz RT, Choi CH, et al. Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clin Proteomics. 2015; 12: 11.
35. Namba T, Hoshino T, Tanaka K, et al. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol. 2007; 71: 860-70.